Optimizing Synthetic Correlated Diffusion Imaging for Breast Cancer Tumour Delineation

Chi-en Amy Tai,Alexander Wong
2024-05-14
Abstract:Breast cancer is a significant cause of death from cancer in women globally, highlighting the need for improved diagnostic imaging to enhance patient outcomes. Accurate tumour identification is essential for diagnosis, treatment, and monitoring, emphasizing the importance of advanced imaging technologies that provide detailed views of tumour characteristics and disease. Synthetic correlated diffusion imaging (CDI$^s$) is a recent method that has shown promise for prostate cancer delineation compared to current MRI images. In this paper, we explore tuning the coefficients in the computation of CDI$^s$ for breast cancer tumour delineation by maximizing the area under the receiver operating characteristic curve (AUC) using a Nelder-Mead simplex optimization strategy. We show that the best AUC is achieved by the CDI$^s$ - Optimized modality, outperforming the best gold-standard modality by 0.0044. Notably, the optimized CDI$^s$ modality also achieves AUC values over 0.02 higher than the Unoptimized CDI$^s$ value, demonstrating the importance of optimizing the CDI$^s$ exponents for the specific cancer application.
Image and Video Processing,Computer Vision and Pattern Recognition
What problem does this paper attempt to address?
This paper aims to address the issue of accurate identification of breast cancer tumors to improve the accuracy of diagnosis, treatment planning, and monitoring. Specifically, the study improves the delineation of breast cancer tumor boundaries by optimizing the coefficients in the synthetic correlated diffusion imaging (CDIs) technique. The authors employ the Nelder-Mead simplex optimization strategy to maximize the area under the receiver operating characteristic curve (AUC) to evaluate the performance of different imaging modalities in distinguishing healthy tissue from tumor tissue. The study results show that the optimized CDIs modality outperforms the non-optimized CDIs modality and the existing gold standard modality in terms of AUC value, indicating the importance of optimizing CDI indices for specific cancer applications.